In the example of SUPT5H, NGS has allowed the identification of a new trans-acting factor gene involved in regulating beta-globin gene expression, which results in beta-thalassemia trait when haploinsufficient. The gene discussed is SUPT5H; the disease is Beta-thalassemia.